PP405 and GT20029 are new hair loss treatments with different mechanisms from traditional options like Minoxidil and Finasteride. PP405 targets hair follicle stem cells to reactivate growth, while GT20029 works as an androgen receptor deleter, both requiring ongoing use for effectiveness.
A user shared their hair regrowth journey since December, using Minoxidil, Saw Palmetto, and Biotin. They included photos to show progress, with one taken in the sun and others with flash.
A user shared impressive hair growth results after 77 days using oral finasteride, topical minoxidil, and weekly microneedling. They reported thicker, darker hair and minimal shedding, with treatment costs around 30 euros per month.
A user shared a six-month update on hair improvement using Pyrilutamide and Minoxidil, noting significant hair regrowth and strength. Some participants questioned the legitimacy of the results and the source of Pyrilutamide.
Significant hair improvement in 3 months using topical 5% Minoxidil twice daily, 1mg Finasteride on alternating days, and weekly microneedling. Users express encouragement and admiration for the progress.
The user shared progress photos of hair regrowth using a topical spray with 0.3% finasteride and 6% minoxidil, applied daily. They experienced significant shedding initially, but hair loss stopped and noticeable regrowth began around 16-18 months, with improved hair color and no side effects.
A 47-year-old with significant hair loss tried Happy Head, micro needling, Pura D’Or Shampoo, and various vitamins for three months. The user shared progress pictures showing improvement.
A user noticed non-itchy, non-bleeding spots on their scalp while experiencing hair loss. Replies suggest the spots are likely sunspots or liver spots and recommend seeing a dermatologist; hair loss is attributed to male pattern baldness.
The user shared progress pictures after 4 months of using 5% topical minoxidil and microneedling for hair loss. They discussed their positive results and experiences with these treatments.